Epidemiological profile and temporal trend of hospitalizations for malignant skin neoplasms in Brazil between 2015 and 2025
DOI:
https://doi.org/10.15343/0104-7809.202650e19952026PKeywords:
Skin Neoplasms, Epidemiology, Public Health, Ultraviolet RaysAbstract
This study analyzed the epidemiological profile and temporal trend of hospitalizations for malignant skin neoplasms in Brazil between 2015 and 2025, based on secondary data from the Hospital Information System of the Unified Health System (SIH/SUS). A total of 633,457 hospitalizations were recorded during the period, with a predominance of male sex (51.9%), self-declared White individuals (65.8%), and the age group of 60 years or older (72.3%). The Southeast and South regions concentrated the highest number of hospitalizations, while the North region presented the highest mortality rate (4.70%). A general upward trend was observed throughout the historical series, with a reduction in 2020 and a progressive recovery in subsequent years. The findings indicate a higher occurrence of hospitalizations in groups more vulnerable to cumulative ultraviolet radiation exposure and evidence regional inequalities in access to diagnosis and treatment, reinforcing the need for prevention strategies, early diagnosis, and strengthening of public health policies.
Downloads
Translations of this article
References
Arnold M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495-503. DOI:10.1001/ jamadermatol.2022.0160.
Langselius O, et al. Global burden of cutaneous melanoma incidence attributable to ultraviolet radiation in 2022. Int J Cancer. 2025;157(6):1110-1119. DOI: 10.1002/ijc.35463.
Zhang X, et al. Global, regional and national trends in melanoma and non-melanoma skin cancer burden from 1990 to 2021: a Global Burden of Disease study. Sci Rep. 2025;15(1):1-12.
Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016;136(6):1161-1171. DOI: 10.1016/j.jid.2016.01.035.
Schadendorf D, et al. Melanoma. Lancet. 2018;392(10151):971-984. DOI: 10.1016/S0140-6736(18)31559-9.
Lucas RM, et al. Human health in relation to exposure to solar ultraviolet radiation under changing stratospheric ozone and climate. Photochem Photobiol Sci. 2019;18(3):641-680. DOI: 10.1039/c8pp90060d.
Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4757. DOI: 10.1136/bmj.e4757.
Ministério da Saúde (BR). Departamento de Informática do SUS. Sistema de Informações Hospitalares do SUS (SIH/SUS) [base de dados na Internet]. Brasília: DATASUS; 2024 [acesso em 4 mar 2026]. Disponível em: http://datasus.saude.gov.br/
Organização Mundial da Saúde. CID-10: Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde [base de dados na Internet]. 10. rev. São Paulo: Universidade de São Paulo; 2008 [acesso em 2 mar 2026]. Disponível em: http://www.paho.org/bra/
Karimkhani C, et al. The global burden of melanoma: results from the Global Burden of Disease Study. Br J Dermatol. 2017;177(1):134-140. DOI: 10.1111/bjd.15510.
Garbe C, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer. 2022;170:236 255. DOI: 10.1016/j.ejca.2022.03.008.
Duquia RP, et al. Prevalence of sun exposure and its associated factors in southern Brazil: a population-based study. An Bras Dermatol. 2013;88(4):554 561. DOI:10.1590/abd1806-4841.20132122
Moreno M, Batista FRB, Bonetti TC. Sobrevida de pacientes com melanoma cutâneo na região Oeste de Santa Catarina, Brasil. Rev Bras Cancerol. 2012;58(4):649-653. DOI: 10.32635/2176-9745.RBC.2012v58n4.567.
Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro: INCA; 2022. [acesso em 2 mar 2026]. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069 1080. DOI: 10.1111/j.1365-2133.2012.10830.x.
Sociedade Brasileira de Dermatologia. Campanha nacional de prevenção ao câncer da pele: dados epidemiológicos. An Bras Dermatol. 2008;83(4): DOI: 10.1590/S0365-05962008000400004.
Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR Morb Mortal Wkly Rep. 2015;64(21):591-596.
Holman DM, Freeman MB, Shoemaker ML. Trends in melanoma incidence among non-Hispanic whites in the United States, 2005 to 2014. JAMA Dermatol. 2018;154(3):361-362. DOI: 10.1001/jamadermatol.2017.5541.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 O Mundo da Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
